COVID-19 Vaccine News & Resources
The COVID-19 pandemic has presented the world with unprecedented health challenges that affect every element of life. Read NAHC’s official Resolution on the COVID-19 Vaccine.
To access NAHC’s main COVID-19 Resources page, click here.
Healthcare Workers: Information on COVID-19
Go here for important information for health care workers and COVID-19
COVID-19 Vaccine Mandate News & Analysis
CMS Issues Guidance on the Vaccine Mandate for all States (Jan 24, 2022)
OSHA Withdraws Temporary COVID-19 Vaccine-or-Testing Rule (Jan 25, 2022)
OSHA Withdraws Most Provisions of the Healthcare ETS (Jan 5, 2022)
As of Friday at 8 a.m. EDT, the unofficial U.S. COVID toll was 79,742,036 cases and 973,273 deaths, increases of 37,329 and 1,413, respectively, from the same time yesterday.
As of March 9, 2022, the current 7-day moving average of daily new cases (37,147) decreased 28.8% compared with the previous 7-day moving average (52,156). A total of 79,248,406 COVID-19 cases have been reported in the United States as of March 9, 2022.
Currently two variants, Omicron and Delta, are classified as Variants of Concern (VOC) in the United States. CDC Nowcast projections* for the week ending February 19, 2022, estimate the combined national proportion of lineages designated as Omicron to be 100%.
Omicron is extremely contagious. The COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, getting hospitalized, and even dying. Everyone in the United States ages 5 years and older is eligible to receive a COVID-19 vaccine. Everyone ages 12 years and older is eligible to receive a COVID-19 booster dose if enough time has passed since completion of their primary series. To find a vaccine provider near you, visit vaccines.gov.
Total Cases Reported
Current 7-Day Average**
Prior 7-Day Average
Change in 7-Day Average since Prior Week
The current 7-day moving average of new deaths (1,559) has decreased 8.9% compared with the previous 7-day moving average (1,712). As of March 2, 2022, a total of 952,223 COVID-19 deaths have been reported in the United States.
New Hospital Admissions
The current 7-day daily average for February 23-March 1, 2022, was 4,243. This is a 30.3% decrease from the prior 7-day average (6,089) from February 16-February 22, 2022.
As of March 9, 2022, 555.9 million vaccine doses have been administered in the United States. Overall, about 254.3 million people, or 76.6% of the total U.S. population, have received at least one dose of vaccine. About 216.4 million people, or 65.2% of the total U.S. population, have been fully vaccinated.* About 95.5 million additional or booster doses have been reported in people who have been fully vaccinated; however, 49.9% of the total booster-eligible population has not yet received a booster dose. As of March 9, 2022, the 7-day average number of administered vaccine doses reported (by date of CDC report) to CDC per day was 302,787, a 11.9% decrease from the previous week.
CDC’s COVID Data Tracker Vaccination Demographic Trends tab shows vaccination trends by age group and by race/ethnicity. As of March 9, 2022, 95.0% of people ages 65 years or older have received at least one dose of vaccine and 88.8% are fully vaccinated. For people ages 5–11 years, only 26.5% are fully vaccinated. For people ages 5 years or older, 81.4% have received at least one dose of vaccine and 69.3% are fully vaccinated. Of the fully vaccinated population, people ages 75 years or older have the highest proportion of additional/booster doses (68.9%) while people ages 12–17 have the lowest proportion (22.0%).
As of March 9, 2022, of all race/ethnicity groups, the Asian non-Hispanic population has the highest proportion that is fully vaccinated (60.1%), and the Black non-Hispanic population has the lowest proportion that is fully vaccinated (41.0%). Of the fully vaccinated population, the Asian non-Hispanic population has the highest proportion of additional/booster doses (66.5%), while the Hispanic/Latino population has the lowest proportion (39.7%).
COVID Data Tracker’s COVID-19 Vaccination Equity tab shows vaccination trends by urban/rural status. As of March 9, 2022, 48.7% of people in rural counties are fully vaccinated, while the range of vaccination coverage in the 4 urban/metro counties ranged from 52.6% (micropolitan) to 66.4% (large central metro).
Two new CDC reports show that people who are up to date with their COVID-19 vaccines have the highest amount of protection against both the Delta and Omicron variants.1,2 One report found that, compared to up-to-date adults, unvaccinated adults had five times the risk of infection and more than 50 times the risk of COVID-19-associated death. A second report found that a third dose (either an additional primary dose or booster dose) of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) was highly effective at preventing emergency and urgent care visits and hospitalizations related to COVID-19.
COVID Data Tracker’s Hospitalizations by Vaccination Status – COVID-NET tab features more new data showing the effectiveness of vaccines and boosters. In December 2021, for example, unvaccinated adults ages 65 years and older were 49 times more likely to be hospitalized for COVID-19 than people in that age group who were up to date with their COVID-19 vaccines.
All of this information highlights the importance of staying up to date with COVID-19 vaccination, given how easily the Omicron variant spreads. As of January 27, 2022, 67.6% of people ages 5 years and older in the United States are fully vaccinated. However, there are still millions of people who are eligible for a booster dose who have not yet received one. Everyone 12 years and older who has received their primary series of a COVID-19 vaccine is now eligible for a booster shot if enough time has passed since completion of their primary series. It’s fast, easy, and free.
- COVID Data Tracker’s County View tab now displays booster dose data at the state level.
- COVID Data Tracker’s COVID-19 Vaccine Effectiveness tab now includes a new data source, Protect.
- Effectiveness of a Third Dose of mRNA Vaccines against COVID-19-associated Emergency Department and Urgent Care Encounters and Hospitalizations during Periods of Delta and Omicron Variant Predominance — VISION Network, Ten States, August 2021–January 2022, MMWR
- COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021
- Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
- COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
- Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022
OLDER IMPORTANT NEWS
- COVID-19 VACCINE ANNOUNCEMENT ON AUGUST 18TH I PARTNER PACKET
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults
- New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status
Centers for Disease Control and Prevention
- Guidance Regarding Mask Wearing
- CDC Guidelines for Vaccinated People
- Interim Public Health Recommendations for Fully Vaccinated People
- Considerations for Homebound Persons
- COVID-19 Vaccination Communication Toolkit for Community-Based Organizations
- COVID-19 Vaccination Communication Toolkit for Essential Workers
- Interim Clinical Considerations for Use of Pfizer-BioNTech COVID-19 Vaccine | CDC
- Pfizer-BioNTech COVID-19 Vaccine
- Answering Patient’s Questions on Vaccines
- Healthcare Professionals: Preparing for COVID-19 Vaccinations
- Post Vaccine Considerations for Healthcare Personnel
- COVID-19 ACIP Vaccine Recommendations
- New V-Safe After Vaccination Health Checker
- CDC’s COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- Healthcare Professionals: Preparing for COVID-19 Vaccination
- 8 Things to Know about Vaccine Planning
- How CDC Is Making COVID-19 Vaccine Recommendations
- Ensuring the Safety of COVID-19 Vaccines in the United States
- Vaccine Information for You and Your Family
- Promoting Vaccination in the Workplace
Centers for Medicare & Medicaid Services
- COVID-19 Vaccine Codes: Updated Effective Date for Moderna
- Enrollment for Administering COVID-19 Vaccine Shots
National Institutes of Health
- Study of Healthcare Workers Shows COVID-19 Immunity Lasts Many Months
- Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
- NIH Director Predicts Vaccinations Will Start This Month
Other Vaccine Links
- New York Times: Coronavirus Vaccine Tracker
- FDA: COVID-19 Vaccines
- Mayo Clinic: COVID-19 vaccines: Get the facts
- RAPS: COVID-19 vaccine tracker
- COVID-19 and Mesothelioma